Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Grossman

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
American Journal of Public Health|December 19, 2009
The longevity gap between Black and White men in the United States at the beginning and end of the 20th centuryFrank A Sloan, Padmaja Ayyagari, Martin Salm, et al.
Obstetrics and Gynecology|March 31, 2004
Routine follow-up visits after first-trimester induced abortionDaniel Grossman, Charlotte Ellertson, David A Grimes, et al.
Contraception|April 15, 2019
Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologistsNeko M Castleberry, Lauren Stark, Jay Schulkin, et al.
JAMA Pediatrics|April 17, 2023
Accuracy of Self-assessment of Gestational Duration Among Adolescents Seeking Abortion Using Information in Addition to Date of Last Menstrual PeriodLauren Ralph, M Antonia Biggs, Katherine Ehrenreich, et al.
Contraception|April 8, 2024
Do miscarriage care practice recommendations align with individuals' needs?: A scoping reviewSofía Filippa, Ruvani T Jayaweera, Kelly Blanchard, et al.
Contraception|May 15, 2020
Mifepristone-misoprostol versus misoprostol-alone regimen for medication abortion at ≥24 weeks' gestationErin Wingo, Sarah Raifman, Carmen Landau, et al.
Contraception|October 29, 2022
Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion productM Antonia Biggs, Sabrina Serrano, Ena Suseth Valladares, et al.
Contraception|May 21, 2018
Evaluating the capacity of California's publicly funded universities to provide medication abortionSarah Raifman, Patricia Anderson, Shelly Kaller, et al.
Contraception|December 12, 2012
Misoprostol in women's hands: a harm reduction strategy for unsafe abortionAlyson Hyman, Kelly Blanchard, Francine Coeytaux, et al.
Journal of Pharmacy Practice|November 4, 2017
Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in CaliforniaKevin Vu, Sally Rafie, Kate Grindlay, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
American Journal of Public Health|December 19, 2009
The longevity gap between Black and White men in the United States at the beginning and end of the 20th centuryFrank A Sloan, Padmaja Ayyagari, Martin Salm, et al.
Obstetrics and Gynecology|March 31, 2004
Routine follow-up visits after first-trimester induced abortionDaniel Grossman, Charlotte Ellertson, David A Grimes, et al.
Contraception|April 15, 2019
Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologistsNeko M Castleberry, Lauren Stark, Jay Schulkin, et al.
JAMA Pediatrics|April 17, 2023
Accuracy of Self-assessment of Gestational Duration Among Adolescents Seeking Abortion Using Information in Addition to Date of Last Menstrual PeriodLauren Ralph, M Antonia Biggs, Katherine Ehrenreich, et al.
Contraception|April 8, 2024
Do miscarriage care practice recommendations align with individuals' needs?: A scoping reviewSofía Filippa, Ruvani T Jayaweera, Kelly Blanchard, et al.
Contraception|May 15, 2020
Mifepristone-misoprostol versus misoprostol-alone regimen for medication abortion at ≥24 weeks' gestationErin Wingo, Sarah Raifman, Carmen Landau, et al.
Contraception|October 29, 2022
Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion productM Antonia Biggs, Sabrina Serrano, Ena Suseth Valladares, et al.
Contraception|May 21, 2018
Evaluating the capacity of California's publicly funded universities to provide medication abortionSarah Raifman, Patricia Anderson, Shelly Kaller, et al.
Contraception|December 12, 2012
Misoprostol in women's hands: a harm reduction strategy for unsafe abortionAlyson Hyman, Kelly Blanchard, Francine Coeytaux, et al.
Journal of Pharmacy Practice|November 4, 2017
Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in CaliforniaKevin Vu, Sally Rafie, Kate Grindlay, et al.
Pageof 29